Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

Lizhu Pharmaceutical Group, Health Yuan Pharmaceutical Group, and Zhihua Technology have launched a strategic cooperation to jointly promote the application of AI in process chemistry.

Published Time:

2021-08-03

In June 2021, Chemical.AI, a research and technology company empowering chemistry with AI, announced a strategic partnership with CSPC Pharmaceutical Group and HealthGen Biotech, companies dedicated to discovering and supporting leading pharmaceutical innovation technologies and products in China. The three parties will combine their respective strengths, including Chemical.AI's leading computer-aided retrosynthesis route design system, and the process chemistry expertise and experience of CSPC Pharmaceutical and HealthGen Biotech, to develop process chemistry modules and promote process chemistry research and development using AI retrosynthesis technology.
 
Process chemistry plays a crucial role in the middle and late stages of drug development, all the way to market launch. The routes used by medicinal chemists to synthesize small amounts of compounds in the laboratory are merely a starting point. The industrial and commercial production of pharmaceuticals requires process chemistry that meets a series of stringent requirements, including green chemistry principles, production safety, cost control, high feasibility of operational routes, and clear patent scope. This necessitates extensive and time-consuming research from pharmaceutical companies. Chemical.AI's AI retrosynthesis platform, after years of development, has successfully achieved commercialization and is actively improving efficiency in drug chemistry research and development. CSPC Pharmaceutical and HealthGen Biotech possess extensive expert knowledge and experience in various drug syntheses and process chemistry, providing real-world case studies and data to support and guide the development of the AI retrosynthesis platform at the process development level. The three parties expect to further empower process chemistry through AI technology platforms, improving industrial output efficiency and accelerating drug development.
 
Dr. Xia Ning, founder and CEO of Chemical.AI, stated: "Artificial intelligence will bring new development potential and opportunities to China's pharmaceutical industry. Empowering drug development with AI can effectively improve efficiency and save costs at various stages of pharmaceutical research and development. We are pleased to join hands with CSPC Pharmaceutical and HealthGen Biotech to leverage our respective strengths and jointly address the challenges and pain points in new drug development, accelerating the application of AI retrosynthesis in the field of process chemistry and achieving mutual win-win cooperation."
 
Dr. Liu Jianing, Chief Investment Officer of CSPC Pharmaceutical Group, stated: "In drug development, chemical process research is a key link in the transformation of drugs from laboratory to industrial production, and is important work for pharmaceutical companies to clarify the feasibility of drug formation and industrial scale-up. CSPC Pharmaceutical Group, together with its parent company HealthGen Biotech, is pleased to conduct in-depth cooperation with Chemical.AI to promote the application of AI technology in the development of green, safe, and efficient chemical synthesis processes."
 
 
About Chemical.AI
Chemical.AI is a research and technology company that empowers chemistry with AI. It uses artificial intelligence technology, chemical big data, and machine learning to develop tools that significantly improve the efficiency of chemical research, aiming to build an intelligent compound planning platform and shape the future of chemistry.
Established in Wuhan in 2018, Chemical.AI has a branch office in Shanghai. The team consists of experts in cheminformatics and chemical synthesis, as well as outstanding IT professionals. Currently, Chemical.AI has successfully provided technical services to many well-known pharmaceutical companies and CROs in China and abroad, and has engaged in in-depth cooperation in areas such as synthesis route and process route design.

 

——From Chemical.AI Official Account